This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Transgene SA
Transgene SA, a pioneering biotechnology company headquartered in France, focuses on the development of innovative immunotherapies for cancer and infectious diseases. Founded in 1998, Transgene has established itself as a leader in the field, with significant operations across Europe and North America. The company is renowned for its proprietary viral vector technology, which underpins its core products, including therapeutic vaccines and oncolytic viruses. These unique offerings aim to harness the body’s immune system to target and destroy cancer cells effectively. With a strong market position, Transgene has achieved notable milestones, including successful clinical trials and strategic partnerships that enhance its research capabilities. As a key player in the biotechnology industry, Transgene continues to drive advancements in immunotherapy, contributing to the future of personalised medicine.
DitchCarbon Score
How does Transgene SA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Transgene SA's score of 32 is higher than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Transgene SA's reported carbon emissions
In 2022, Transgene SA reported total carbon emissions of approximately 3,340,000 kg CO2e. This figure includes 20,000 kg CO2e from Scope 1 emissions, which are direct emissions from owned or controlled sources, and 149,000 kg CO2e from Scope 2 emissions, representing indirect emissions from the generation of purchased electricity, steam, heating, and cooling. The majority of their emissions, about 3,170,000 kg CO2e, fall under Scope 3, which encompasses all other indirect emissions that occur in the value chain. As of the latest data, Transgene SA has not set specific reduction targets or initiatives, nor are there any climate pledges reported. The company operates as a current subsidiary, and the emissions data is cascaded from its own reporting, with no additional data inherited from a parent organization. Transgene SA's commitment to addressing climate change is evident through its emissions reporting, although further details on specific reduction strategies or targets are currently unavailable.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | |
|---|---|
| Scope 1 | 20,000 |
| Scope 2 | 149,000 |
| Scope 3 | 3,170,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Transgene SA is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
